Fabuloso Recall 2024 Symptoms Pdf. (as of march 23, 2022) actemra (tocilizumab) drug reaction with eosinophilia and systemic. Potential signal of a serious risk / new safety information.
Potential signal of a serious risk / new safety information. (as of march 23, 2022) actemra (tocilizumab) drug reaction with eosinophilia and systemic.